Increasing geriatric population is expected to drive the growth of global cellular health screening in the forecast period, 2024-2028.
According to TechSci Research report, “Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the global cellular health screening market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing significance of healthy life expectancy and growing concerns from the government towards preventive healthcare across the globe. Additionally, rising geriatric population and increasing research and development projects for different pre-clinical studies can demand for cellular screening and the growing number of campaigns to educate the public about the signs of chronic diseases and how to prevent them in order to contain diseases epidemics, especially in the developed countries in North America and Europe is expected to create lucrative opportunities for the market growth in coming years. Besides, increasing adoption of telomere performance programs for leading a healthy life is further expected to support market growth. Similarly, growing awareness campaigns by different organizations across the globe have played a significant role in increasing the demand for testing based preventive healthcare products and service which will propel the market growth during the forecasted period.
However, rising problem associated with sample’s transportation and the lack of reimbursement policies, can create affordability issues, thereby slowing down the growth of global cellular health screening market in the forecast period. Similarly, difference in the cost kit offered by different organizations may hamper the cellular health screening market growth during the forecast period. Also, lack of awareness about new technology and instability of kits and fragility of samples, making the results less sensitive and less efficient, can further restrict the growth of global cellular health screening market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Cellular Health Screening Market"
The global cellular health screening market can be segmented by test type, by sample, by site of collection and by region. Based on test type, the global cellular health screening market can be divided into Single Test Panels and Multi Test Panels. The multi test panels segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to the increasing research about showing the correlation of telomere length on multiple molecular and cellular functions, along with the launch of new testing devices for the detection of telomere length growth. Also, growing demand for the screening of biomarkers during a single run is expected to demand for cellular health screening market during the forecasted year.
Based on site of collection, the market can be segmented into Home, Hospitals & Clinics, Diagnostic Laboratories, Others. The home segment is expected to dominate during the forecast period on account of the increasing awareness regarding health and self-sampling adoption in major markets. Similarly, the presence of a sample collection site and skilled professionals is also a major factor that will drive the market growth over the years.
Major companies operating in global cellular health screening market are:
- Telomere Diagnostics, Inc.
- Quest Diagnostics, Inc.
- Laboratory Corporation of America Holdings
- SpectraCell Laboratories, Inc.
- Cell Science Systems Corporation
- Immundiagnostik AG
- Repeat Diagnostics, Inc.
- OPKO Health, Inc.
- Genova Diagnostics, Inc.
- Titanovo, Inc.
For instance, as per the article published by theguardian.com, in February 2022, an awareness campaign has been launched in England to increase life-saving screening. This campaign was launched by the Department of Health and Social Care.
For instance, in September 2021, Genomic Vision launched TeloSizer to boost the use of telomere for biomarker discovery via its precise and quantitative detection.
For instance, in a research article published in July 2020, researchers from Japan proved that the presence of pteridine derivatives in urine is associated with oxidative stress and smoking.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in the global cellular health screening market due to the increasing awareness on health, along with growing healthcare expenditure across the region. Furthermore, increasing funding by government organizations for preventive healthcare and increasing number of major key players are further contributing to the demand for cellular health screening. Besides, increasing adoption of new technologies and growing prevalence of infectious and chronic diseases in the population, regionally, is further expected to create lucrative opportunities for the market growth” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Test Type (Single Test Panels v/s Multi Test Panels), By Sample (Blood, Saliva, Urine, Others), By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others), By Region and Competition”, has evaluated the future growth potential of global cellular health screening market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global cellular health screening market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
The growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and the resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market.
On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies are expected to restrain the growth of this market during the forecast period.
The increasing burden of chronic diseases, expansion opportunities for market players, and a growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.The report segments market based on type, sample type, sample collection type, and region.
Cellular health screening comprises four major tests, namely, telomere tests, oxidative stress tests, inflammation tests, and heavy metals tests.
These are risk assessment tests that help detect biological age, cellular toxicity, and the risk of diseases.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930Single test panels are used to examine individual biomarkers for specific results, while tests for a combination of cellular biomarkers are carried out using multi-test panels/kits.
With reference to the report published by the authorities the scope of the global Cellular Health Screening Market was priced at US$ 1.9 billion in 2018.
It is expected to observe a CAGR of 9.3% for the duration of the forecast to reach US$ 3.8 billion by 2026.
This comprises perfect information of in what way dissimilar physical structures are working and in what way the procedure of aging have affected them.
For the most part, the perfect information of the body’s process and working delivers the physicians a strong image to come about with additionally effectual directed organization and plans of treatment for a number of complaints.
Drivers: Speedily increasing acceptance of direct to customer methodology, growth in the necessity for cellular health screening, development in research actions, and increase in inventiveness by the government authorities for precautionary healthcare.
Restraints: On the other hand, variances in the prices of kits presented by the companies and difficulties linked with the transportation of samples may possibly restrain the development of the global cellular health screening market.
Factors such as the increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market.
[140 Pages Report] The global cellular health screening market is estimated to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period.Cellular Health Screening/ Health Testing Market by Type (Single (Telomere, Oxidative Stress, Inflammation, Heavy Metal), Multitest), Sample (Blood, Saliva, Serum, Urine), Collection Site (Home, Office, Hospital, Diagnostic Labs), and Region - Global Forecast to 2022Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930What drives the Market?Increasing Adoption of Telomere Performance Programs for Leading A Healthy LifeGrowing Importance of Healthy Life Expectancy (HALE)Rising Government Focus towards Preventive HealthcareRising Geriatric Population and Resultant Growth in the Need for Cellular Health ScreeningIncreasing Research ActivitiesBurden of Chronic DiseasesOn the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies are expected to restrain the growth of this market during the forecast period.Stakeholders: Cellular health screening service providersClinical laboratoriesHealthcare institutions (hospitals and outpatient clinics)Academic institutes and universitiesDistributors and suppliers of cellular health screening kits and servicesNorth America is expected to account for the largest share of the marketNorth America is expected to account for the largest share of the market, followed by Europe.
However, Asia is projected to register the highest CAGR during the forecast period.
The high growth of the Asian market can be attributed to the rising geriatric population, increasing burden of chronic diseases, expansion opportunities for market players, and growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.Key PlayersThe global market is highly competitive with the presence of several small and big players.
Prominent players in the cellular heath screening market include Genova Diagnostics (US), Telomere Diagnostics (US), Life Length (Spain), Quest Diagnostics (US), Repeat Diagnostics (Canada), SpectraCell Laboratories (US), Zimetry LLC (US), Cell Science Systems (US), Titanovo, Inc. (US), Segterra, Inc. (US), LabCorp Holdings (US), BioReference Laboratories (US), Immundiagnostik AG (Germany), and Cleveland HeartLab, Inc. (US).Key Players @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=227041930Major Market Developments: In 2016, Telomere Diagnostics launched TeloYears, its new telomere test.In 2015, SpectraCell announced the expansion of its specialized testing menu to include several new diagnostic panels for cardiometabolic biomarkers, pre-diabetic screening, male and female hormone panels, thyroid, and adrenal function and cardiovascular-related genetic tests.In 2016, Life Length partenered with Eastern Biotech & Life Sciences to launch telomere tests in GCC countries.In 2015, Titanovo launched an at-home, saliva-based telomere testing kit.
